ORTHO-CEPT Drug Patent Profile
✉ Email this page to a colleague
When do Ortho-cept patents expire, and when can generic versions of Ortho-cept launch?
Ortho-cept is a drug marketed by Janssen Pharms and is included in one NDA.
The generic ingredient in ORTHO-CEPT is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ortho-cept
A generic version of ORTHO-CEPT was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ORTHO-CEPT?
- What are the global sales for ORTHO-CEPT?
- What is Average Wholesale Price for ORTHO-CEPT?
Summary for ORTHO-CEPT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Patent Applications: | 217 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ORTHO-CEPT at DailyMed |
![ORTHO-CEPT drug patent expirations Drug patent expirations by year for ORTHO-CEPT](/p/graph/s/t/ORTHO-CEPT-patent-expirations.png)
![Drug Sales Revenue Trends for ORTHO-CEPT](/p/graph/drug-sales-revenues/ORTHO-CEPT.png)
US Patents and Regulatory Information for ORTHO-CEPT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | ORTHO-CEPT | desogestrel; ethinyl estradiol | TABLET;ORAL-21 | 020301-001 | Dec 14, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Janssen Pharms | ORTHO-CEPT | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 020301-002 | Dec 14, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ORTHO-CEPT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | ORTHO-CEPT | desogestrel; ethinyl estradiol | TABLET;ORAL-21 | 020301-001 | Dec 14, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | ORTHO-CEPT | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 020301-002 | Dec 14, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ORTHO-CEPT
See the table below for patents covering ORTHO-CEPT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 414771 | FORFARANDE FOR FRAMSTELLNING AV NYA 11,11-ALKYLIDEN-STEROIDER | ⤷ Sign Up |
Mexico | 9203790 | UN PROCEDIMIENTO PARA LA PREPARACION DE NUEVOS 11,11-ALCOHILIDEN-ESTEROIDES. | ⤷ Sign Up |
Finland | 54128 | ⤷ Sign Up | |
Canada | 1021318 | 11,11-ALKYLIDENE STEROIDS | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |